Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 4/20 | 0.40 |
| ▸ | KCNK2 | O95069 | 3/20 | 0.40 |
| ▸ | KCNK10 | P57789 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | PDE2A | O00408 | 3/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | TACR1 | P25103 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26413574 | 0.84 | OPRM1 (0.41) | OPRM1MAPTTSHRHTTHDAC1 | |
| SCHEMBL24943664 | 0.83 | OPRM1 (0.46) | LMNAOPRM1TSHRHDAC1TACR1 | |
| SCHEMBL24944313 | 0.81 | ESR1 (0.42) | LMNAOPRM1MAPTTSHRMAPK1 | |
| SCHEMBL26413775 | 0.81 | ALDH1A1 (0.46) | LMNAOPRM1TSHRHDAC1 | |
| SCHEMBL24943754 | 0.81 | SMN1; SMN2 (0.43) | OPRM1MAPTTSHRMAPK1HDAC1 | |
| SCHEMBL24944620 | 0.80 | DRD2 (0.43) | OPRM1MAPTTSHRHDAC1TACR1 | |
| SCHEMBL24943674 | 0.80 | NPC1 (0.43) | LMNAOPRM1MAPTTSHRHDAC1 | |
| SCHEMBL24944860 | 0.80 | OPRM1 (0.47) | OPRM1MAPTHDAC1TACR1 | |
| SCHEMBL24944081 | 0.80 | OPRM1 (0.44) | LMNAOPRM1MAPTHDAC1 | |
| SCHEMBL26413644 | 0.80 | PARP10 (0.44) | LMNAOPRM1MAPTTSHRHDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11644753-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-09 | — | — | US | disclosed |
| US-20230131303-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20230021453-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11644753-B2 | Resist composition and patterning process | HNRNPU, NSUN2, HNRNPR | CHRM5 3920/4885KCNK2 1678/4885KCNK10 2414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.